Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mário Henrique Meine"'
Autor:
Marcos Mucenic, Ajacio Bandeira de Melo Brandão, Claudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Maria Lucia Zanotelli, Ian Leipnitz, Mário Henrique Meine, Guillermo Kiss, Juliano Martini, Eduardo Soares Schlindwein, Ane Micheli Costabeber, Fernanda Karlinsky Rodrigues Sacco, Giovana Rossato, Guido Pio Cracco Cantisani
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 61, Iss 0 (2019)
ABSTRACT Chronic Hepatitis C relapse after liver transplantation can lead to graft failure within a short time period. The high efficacy and good safety profile of direct-acting antivirals has led to consensual recommendations for using interferon-fr
Externí odkaz:
https://doaj.org/article/1a86acac792b4e9d922af31469fed7f6
Autor:
Adriana, Machado, Guillermo, Kiss, Lucas, Ernani, Claudio, Marroni, Maria Lúcia, Zanotelli, Guido, Cantisani, Carlos Thadeu, Cerski, Gabriela, Coral, Ajacio, Brandão, Mário Henrique, Meine
Publikováno v:
Clinical transplantation. 29(9)
This retrospective study evaluated the ability of the Metroticket model to predict five-yr post-transplant survival in patients with hepatocellular carcinoma (HCC) based only on explant data. Five-yr survival after transplant was estimated using the
Autor:
Mucenic, Marcos, Ajacio Bandeira de Melo Brandão, Claudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Maria Lucia Zanotelli, Leipnitz, Ian, Mário Henrique Meine, Kiss, Guillermo, Martini, Juliano, Eduardo Soares Schlindwein, Ane Micheli Costabeber, Fernanda Karlinsky Rodrigues Sacco, Rossato, Giovana, Guido Pio Cracco Cantisani
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo; 2019, Vol. 61, p1-4, 4p
Autor:
Ane Micheli, Costabeber, Marioni, Granzotto, Alfeu de Medeiros, Fleck, Cláudio Augusto, Marroni, Maria Lúcia, Zanotelli, Guido, Cantisani, Lívia, Lionço, Maiara Isabel, Musskopf, Ajácio, Brandão, Mário Henrique, Meine
Publikováno v:
Annals of hepatology. 12(6)
Liver retransplantation (LReTx) is the therapeutic option for hepatic graft failure. Survival after LReTx is poorer than after primary liver transplantation. Given the organ shortage, it is essential to optimize the use of this resource.To evaluate r